HHMI
AVXS

Howard Hughes Medical Institute’s AveXis, Inc. Common Stock AVXS Stock Holding History

Howard Hughes Medical Institute’s Portfolio AVXS Stock Details AVXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-642
Closed -$53K – 151
2017
Q2 		$53K Buy
+642
New +$48.1K 0.01% 148

Other funds holding AVXS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Howard Hughes Medical Institute's AVXS Position: Q3 2017 in Review

Howard Hughes Medical Institute sold out of AveXis, Inc. Common Stock (AVXS) in Q3 2017, closing a stake of 642 shares — an estimated $53K sold.

Howard Hughes Medical Institute first reported a position in AVXS in Q2 2017 and held it in 1 quarter. The position peaked at $53K in Q2 2017. 145 funds tracked by Wall St. Rank hold AVXS as of Q3 2017.

  • Howard Hughes Medical Institute reported no remaining AveXis, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 642 AveXis, Inc. Common Stock shares in Q3 2017, an estimated $53K.
  • Howard Hughes Medical Institute first reported a position in AveXis, Inc. Common Stock in Q2 2017 and held it in 1 quarter.
  • Howard Hughes Medical Institute's AveXis, Inc. Common Stock position peaked at $53K in Q2 2017.
  • 145 funds tracked by Wall St. Rank held AveXis, Inc. Common Stock as of Q3 2017.

Based on Howard Hughes Medical Institute's 13F filing for Q3 2017, filed 2 Nov 2017.